Jeff Yass’s Medpace MEDP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $69.9M | Buy |
132,000
+118,100
| +850% | +$54.5M | 0.01% | 1252 |
|
|
2026
Q1 | $6.67M | Sell |
13,900
-17,800
| -56% | -$9.11M | ﹤0.01% | 3750 |
|
|
2025
Q4 | $17.8M | Sell |
31,700
-86,400
| -73% | -$49M | ﹤0.01% | 2335 |
|
|
2025
Q3 | $60.7M | Buy |
118,100
+47,200
| +67% | +$20.6M | 0.01% | 1210 |
|
|
2025
Q2 | $22.3M | Buy |
70,900
+34,300
| +94% | +$10.3M | ﹤0.01% | 1899 |
|
|
2025
Q1 | $11.2M | Sell |
36,600
-2,100
| -5% | -$706K | ﹤0.01% | 2387 |
|
|
2024
Q4 | $12.9M | Sell |
38,700
-47,000
| -55% | -$15.9M | ﹤0.01% | 2338 |
|
|
2024
Q3 | $28.6M | Buy |
85,700
+60,000
| +233% | +$22.8M | 0.01% | 1497 |
|
|
2024
Q2 | $10.6M | Buy |
25,700
+14,600
| +132% | +$5.78M | ﹤0.01% | 2415 |
|
|
2024
Q1 | $4.49M | Buy |
11,100
+2,800
| +34% | +$984K | ﹤0.01% | 3796 |
|
|
2023
Q4 | $2.54M | Buy |
8,300
+1,800
| +28% | +$486K | ﹤0.01% | 4868 |
|
|
2023
Q3 | $1.57M | Sell |
6,500
-14,700
| -69% | -$3.76M | ﹤0.01% | 5625 |
|
|
2023
Q2 | $5.09M | Buy |
21,200
+12,500
| +144% | +$2.6M | ﹤0.01% | 3501 |
|
|
2023
Q1 | $1.64M | Sell |
8,700
-6,100
| -41% | -$1.26M | ﹤0.01% | 5585 |
|
|
2022
Q4 | $3.14M | Sell |
14,800
-14,500
| -49% | -$2.9M | ﹤0.01% | 3940 |
|
|
2022
Q3 | $4.61M | Buy |
29,300
+1,800
| +7% | +$287K | ﹤0.01% | 3295 |
|
|
2022
Q2 | $4.12M | Sell |
27,500
-1,700
| -6% | -$246K | ﹤0.01% | 3503 |
|
|
2022
Q1 | $4.78M | Buy |
+29,200
| New | +$4.81M | ﹤0.01% | 3709 |
|
|
2021
Q4 | – | Sell |
-11,800
| Closed | -$2.23M | – | 13582 |
|
|
2021
Q3 | $2.23M | Buy |
11,800
+4,300
| +57% | +$784K | ﹤0.01% | 5589 |
|
|
2021
Q2 | $1.32M | Buy |
7,500
+5,200
| +226% | +$897K | ﹤0.01% | 6977 |
|
|
2021
Q1 | $377K | Sell |
2,300
-14,900
| -87% | -$2.28M | ﹤0.01% | 10116 |
|
|
2020
Q4 | $2.39M | Buy |
17,200
+10,400
| +153% | +$1.31M | ﹤0.01% | 4723 |
|
|
2020
Q3 | $760K | Sell |
6,800
-8,900
| -57% | -$1.03M | ﹤0.01% | 6785 |
|
|
2020
Q2 | $1.46M | Sell |
15,700
-800
| -5% | -$68.1K | ﹤0.01% | 5087 |
|
|
2020
Q1 | $1.21M | Sell |
16,500
-22,500
| -58% | -$1.95M | ﹤0.01% | 4948 |
|
|
2019
Q4 | $3.28M | Hold |
39,000
| – | – | ﹤0.01% | 3557 |
|
|
2019
Q3 | $3.28M | Sell |
39,000
-2,100
| -5% | -$159K | ﹤0.01% | 3352 |
|
|
2019
Q2 | $2.69M | Sell |
41,100
-48,900
| -54% | -$2.82M | ﹤0.01% | 3638 |
|
|
2019
Q1 | $5.31M | Buy |
90,000
+66,100
| +277% | +$3.95M | ﹤0.01% | 2373 |
|
|
2018
Q4 | $1.26M | Sell |
23,900
-9,300
| -28% | -$511K | ﹤0.01% | 4260 |
|
|
2018
Q3 | $1.99M | Buy |
+33,200
| New | +$1.82M | ﹤0.01% | 4009 |
|
Other funds holding MEDP
WA
Jeff Yass's MEDP Position: Q2 2026 in Review
Jeff Yass increased its Medpace (MEDP) stake by 625% in Q2 2026, buying an estimated $2.82M and bringing the position to 7,095 shares worth $3.76M. The position accounts for ﹤0.01% of the portfolio, ranked #5173.
Jeff Yass first reported a position in MEDP in Q2 2017 and has held it in 32 quarters since. The position peaked at $35.1M in Q2 2023. 694 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.
- Jeff Yass held 7,095 shares of Medpace worth $3.76M as of Q2 2026.
- Jeff Yass bought 6,117 Medpace shares in Q2 2026, an estimated $2.82M.
- Medpace made up ﹤0.01% of Jeff Yass's portfolio in Q2 2026, its #5173 holding.
- Jeff Yass first reported a position in Medpace in Q2 2017 and has held it in 32 quarters since.
- Jeff Yass's Medpace position peaked at $35.1M in Q2 2023.
- 694 funds tracked by Wall St. Rank held Medpace as of Q2 2026.
Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.